Can we avoid surgery in elderly patients with renal masses by using the Charlson comorbidity index?
AffiliationDepartment of Urology, St. Vincent's University Hospital, Dublin, Ireland., email@example.com
Aged, 80 and over
Tomography, X-Ray Computed
MetadataShow full item record
CitationBJU Int. 2009 Jun;103(11):1492-5. Epub 2008 Dec 8.
AbstractOBJECTIVE To determine the safety of surveillance for localized contrast-enhancing renal masses in elderly patients whose comorbidities precluded invasive management; to provide an insight into the natural history of small enhancing renal masses; and to aid the clinician in identifying those patients who are most suitable for a non-interventional approach. PATIENTS AND METHODS We conducted a retrospective chart review of 26 consecutive patients (16 men and 10 women), who were followed for > or =1 year, with localized solid enhancing renal masses between 1998 and 2006. These patients were unfit or unwilling to undergo radical or partial nephrectomy. None had their tumours surgically removed. Study variables included age, presentation, tumour size, growth rate, Charlson comorbidity index (CMI) and available pathological data. RESULTS The mean (range) patient age was 78.14 (63-89) year, with a mean follow-up of 28.1 (12-72) months. The mean tumour size was 4.25 (2.5-8.7) cm at diagnosis. The tumour growth rate was 0.44 cm/year; among smaller masses (T1a) it was 0.15 cm/year, vs 0.64 cm/year in the larger masses (T1b and T2). The mean CMI was 2.96. There were 11 deaths overall; 10 patients died from unrelated illnesses. One death was directly attributable to metastatic renal cancer; this patient had an initial tumour diameter of 5.4 cm and a CMI of 6. All patients who died had a CMI of > or =3. CONCLUSIONS Elderly patients with small renal tumours (T1a) and comorbidity scores of > or =3 were more likely to die as a result of their comorbidities rather than the renal tumour. Surveillance of small renal masses appears to be a safe alternative in elderly patients who are poor surgical candidates, where the overall growth rate appears to be slow.
- Active surveillance for selected patients with renal masses: updated results with long-term follow-up.
- Authors: Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S
- Issue date: 2007 Sep 1
- Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome.
- Authors: Lamb GW, Bromwich EJ, Vasey P, Aitchison M
- Issue date: 2004 Nov
- Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
- Authors: Beisland C, Hjelle KM, Reisaeter LA, Bostad L
- Issue date: 2009 Jun
- A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
- Authors: Lane BR, Babineau D, Kattan MW, Novick AC, Gill IS, Zhou M, Weight CJ, Campbell SC
- Issue date: 2007 Aug
- Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention.
- Authors: Rais-Bahrami S, Guzzo TJ, Jarrett TW, Kavoussi LR, Allaf ME
- Issue date: 2009 May